Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume

We retrospectively investigated outcomes, including pulmonary toxicities, of stereotactic body radiation therapy using RapidArc and a risk-adapted 60% isodose plan for early-stage non-small-cell lung cancer patients. We evaluated patients staged as cT1a–2bN0M0 between 2011 and 2017 and treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsurugai, Yuichiro, Takeda, Atsuya, Sanuki, Naoko, Eriguchi, Takahisa, Aoki, Yousuke, Oku, Yohei, Akiba, Takeshi, Sugawara, Akitomo, Kunieda, Etsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Regular Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530627/
https://www.ncbi.nlm.nih.gov/pubmed/30668868
http://dx.doi.org/10.1093/jrr/rry112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530627/
https://www.ncbi.nlm.nih.gov/pubmed/30668868
http://dx.doi.org/10.1093/jrr/rry112

Ejemplares similares